IOVANCE BIOTHERAPEUTICS, INC. Unrealized Gain (Loss) on Investments
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Unrealized Gain (Loss) on Investments of $137.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $52.00K, a 73.33% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was $85.00K, a 22.73% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $14.00K.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was -$100.00K, a 137.17% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2025 was $54.00K, a 30.77% decline from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2024 was $78.00K, a 91.70% decline from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2023 was $940.00K.
- IOVANCE BIOTHERAPEUTICS, INC. unrealized gain (loss) on investments for fiscal 2022 was -$301.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $137.00K 10-Q · filed 2026-08-06 | $151.00K derived: sum of 3 quarters · filed 2026-08-06 | $51.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $85.00K 10-Q · filed 2026-05-07 | $99.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.00K derived: sum of 3 quarters · filed 2026-05-07 | $29.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$86.00K derived: sum of 2 quarters · filed 2026-02-24 | -$56.00K derived: sum of 3 quarters · filed 2026-08-06 | $54.00K 10-K · filed 2026-02-24 | |
| 2025-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$70.00K derived: sum of 2 quarters · filed 2026-08-06 | $40.00K 10-Q · filed 2025-11-06 | -$102.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $140.00K 10-Q · filed 2026-08-06 | -$2.00K derived: sum of 3 quarters · filed 2026-08-06 | $267.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $110.00K 10-Q · filed 2026-05-07 | -$32.00K derived: sum of 2 quarters · filed 2026-05-07 | $237.00K derived: sum of 3 quarters · filed 2026-05-07 | $119.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $127.00K derived: sum of 2 quarters · filed 2026-02-24 | $9.00K derived: sum of 3 quarters · filed 2026-02-24 | $78.00K 10-K · filed 2026-02-24 | |
| 2024-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $151.00K derived: sum of 2 quarters · filed 2025-11-06 | $220.00K 10-Q · filed 2025-11-06 | $248.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | -$118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$49.00K 10-Q · filed 2025-08-07 | -$21.00K derived: sum of 3 quarters · filed 2026-02-24 | -$3.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $69.00K 10-Q · filed 2025-05-08 | -$69.00K 10-Q · filed 2024-05-09 | $97.00K derived: sum of 2 quarters · filed 2026-02-24 | $115.00K derived: sum of 3 quarters · filed 2026-02-24 | $233.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $46.00K derived: sum of 2 quarters · filed 2026-02-24 | $164.00K derived: sum of 3 quarters · filed 2026-02-24 | $940.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $136.00K derived: sum of 2 quarters · filed 2024-11-07 | $912.00K 10-Q · filed 2024-11-07 | $2.05M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $894.00K 10-Q · filed 2024-08-08 | $2.03M derived: sum of 3 quarters · filed 2025-02-27 | $2.69M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $776.00K 10-Q · filed 2024-05-09 | $1.91M derived: sum of 2 quarters · filed 2025-02-27 | $2.57M derived: sum of 3 quarters · filed 2025-02-27 | $2.22M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.79M derived: sum of 2 quarters · filed 2025-02-27 | $1.44M derived: sum of 3 quarters · filed 2025-02-27 | -$301.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $659.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $305.00K derived: sum of 2 quarters · filed 2023-11-07 | -$1.44M 10-Q · filed 2023-11-07 | -$2.03M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | -$354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.10M 10-Q · filed 2023-08-08 | -$2.69M derived: sum of 3 quarters · filed 2024-02-28 | -$2.73M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | -$1.74M 10-Q · filed 2023-05-10 | -$2.34M derived: sum of 2 quarters · filed 2024-02-28 | -$2.38M derived: sum of 3 quarters · filed 2024-02-28 | -$2.44M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$634.00K derived: sum of 2 quarters · filed 2024-02-28 | -$697.00K derived: sum of 3 quarters · filed 2024-02-28 | -$620.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$101.00K derived: sum of 2 quarters · filed 2022-11-03 | -$24.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $14.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $77.00K 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | -$201.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |